Aino Health AB (AINO) AI Stock Analysis

• Market Cap: kr49.51M
• Dividend Yield: N/A
• Average Volume (3M): 31.45K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.95
• Revenue Growth: 9.87%
• EPS Growth: 67.12%
• Country: SE
• Employees: 19
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): >-0.01
• Shares Outstanding: 204,569,100
• 10 Day Avg. Volume: 53,115
• 30 Day Avg. Volume: 31,451
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 29 Underperform
• Price Target: ―

Aino Health AB's overall stock score reflects significant financial weaknesses, including persistent losses and negative equity. The bearish technical indicators compound concerns about its short-term market performance. Despite some minor revenue improvement, the company's negative valuation metrics highlight its ongoing operational challenges, making it a high-risk investment.

Aino Health AB Business Overview & Revenue Model

Company Description

Aino Health AB (publ) provides corporate health management solutions for private and public organizations in Finland. It offers HealthManager, a software as a service solution that provides surveys, analytics, exposure checks, and security and GDPR services; and e-learning platform. The company also provides telemedicine services; professional services, including analytics, management and employee support, and well-being services; onboarding services, such as project management and planning, implementation, and training and communication services; and other services to occupational health care providers, insurance companies, IT software and service companies, HR, payroll service centers, nurses, online therapists, etc. Aino Health AB (publ) is based in Stockholm, Sweden.

How the Company Makes Money

Aino Health AB generates revenue through a subscription-based model, where businesses pay for access to its digital health management platform. The platform provides tools and analytics that help organizations monitor and enhance employee health and productivity. Key revenue streams include subscription fees for the platform, consultancy services related to health management, and partnerships with healthcare providers. The company may also generate income through additional services such as training and workshops aimed at promoting healthy workplace practices.

Aino Health AB Financial Statement Overview

Summary

Aino Health AB faces significant financial challenges, with persistent losses, negative equity, and cash flow difficulties. While there are minor improvements in revenue, the company must address profitability and cash flow issues to stabilize its financial position and ensure long-term sustainability.

Income Statement

The company has experienced fluctuating revenues with a slight increase in the latest year. Gross profit margin remains high, but negative EBIT, EBITDA, and net profit margins indicate ongoing operational challenges. Revenue growth is stagnant with a slight increase in 2024, but profitability remains a significant concern.

Balance Sheet

The company's financial structure is weak, with negative stockholders' equity and a lack of debt. The negative equity and high liabilities suggest potential solvency risks. The lack of leverage may indicate limited financing options or a strategic choice to minimize debt.

Cash Flow

The company consistently reports negative operating and free cash flows, reflecting cash management challenges. Although there is some improvement in financing cash flow, it is insufficient to offset the negative operating cash flows, indicating a need for cash flow improvements.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	25.33M	23.94M	23.92M	19.91M	23.04M	24.92M
Gross Profit	18.75M	21.51M	3.80M	17.77M	21.56M	23.61M
EBITDA	-3.76M	-6.21M	-7.53M	-12.26M	-12.09M	-9.95M
Net Income	-7.53M	-9.91M	-10.66M	-15.37M	-16.52M	-12.77M
Balance Sheet
Total Assets	7.18M	9.86M	13.51M	17.33M	19.02M	33.38M
Cash, Cash Equivalents and Short-Term Investments	1.08M	741.00K	1.44M	2.16M	453.00K	9.00M
Total Debt	0.00	0.00	164.00K	659.00K	1.06M	1.49M
Total Liabilities	8.08M	10.32M	14.37M	19.57M	16.44M	17.36M
Stockholders Equity	-902.00K	-458.00K	-851.00K	-2.23M	2.58M	16.02M
Cash Flow
Free Cash Flow	-3.33M	-4.55M	-6.26M	-12.87M	-8.11M	-12.07M
Operating Cash Flow	-3.33M	-4.55M	-6.26M	-12.87M	-8.11M	-12.07M
Investing Cash Flow	-252.00K	0.00	0.00	1.32M	0.00	1.69M
Financing Cash Flow	3.99M	3.82M	5.57M	13.19M	-450.00K	16.38M

Aino Health AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.20
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:AINO, the sentiment is Positive. The current price of 0.2 is below the 20-day moving average (MA) of 0.23, below the 50-day MA of 0.22, and below the 200-day MA of 0.20, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 54.04 is Neutral, neither overbought nor oversold. The STOCH value of 74.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:AINO.

Aino Health AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CMOTEC.B	54 Neutral	144.73M	-14.65	0.00%	―	113.59%	54.12%
KONT	46 Neutral	69.09M	-41.35	-3.37%	―	-1.24%	-168.20%
PROGEN	35 Underperform	24.79M	-0.26	0.00%	―	-67.76%	95.76%
STABL	34 Underperform	19.08M	-1.39	0.00%	―	0.00%	68.74%
HEART	34 Underperform	99.72M	-1.20	0.00%	―	0.00%	0.00%
AINO	29 Underperform	kr49.51M	―	-363.95%	―	9.87%	67.12%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%